Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Mingyi Wu
Introduction
Mingyi Wu is a notable inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticoagulant agents. His work focuses on creating innovative solutions for thrombotic diseases, showcasing his dedication to advancing medical science.
Latest Patents
Mingyi Wu holds a patent for a depolymerized glycosaminoglycan known as dTHG. This compound has a weight average molecular weight of approximately 8000–20000 Da and includes monosaccharide components such as acetylgalactosamine (GalNAc), glucuronic acid (GlcUA), and fucose (Fuc). The molar ratio of these components is carefully balanced, making dTHG a potent endogenous inhibitor of factor X. This invention demonstrates good anticoagulant and antithrombotic activity, providing a promising avenue for the prevention and treatment of thrombotic diseases.
Career Highlights
Mingyi Wu is currently employed at Shenzhen Neptunus Pharmaceutical Co., Ltd. His role at the company allows him to apply his expertise in developing innovative pharmaceutical products. His work has been instrumental in advancing the company's research and development efforts.
Collaborations
Mingyi Wu collaborates with talented colleagues, including Jinhua Zhao and Hui Kang. These partnerships enhance the research environment and contribute to the successful development of new pharmaceutical solutions.
Conclusion
Mingyi Wu's innovative work in the field of pharmaceuticals, particularly with his patent for dTHG, highlights his commitment to improving healthcare. His contributions are paving the way for advancements in the treatment of thrombotic diseases, showcasing the importance of innovation in medicine.